Virtual Reality for Non-cardiac Chest Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The purpose of this study is to determine if virtual reality (VR) will improve symptoms in non-cardiac chest pain (NCCP).
Eligibility criteria
Qualifiers
Symptoms of non-cardiac chest pain (recurrent anginal-like or atypical chest pain)
Negative prior cardiac evaluation (at a minimum, including electrocardiogram)
Prior esophagogastroduodenoscopy and/or barium esophagram to rule out severe esophagitis, stricture, or motility abnormality
Disqualifiers
Initiation of a proton pump inhibitor (PPI) within 8 weeks
Major concomitant illness
Current drug or alcohol use that that would interfere with adherence to study requirements
Symptoms of vertigo or dizziness that would limit tolerability of the VR headset
Trial design
Treatments tested in this trial
- Virtual Reality
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov